MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab-Reference-Cited by-同舟云学术

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab

Published:2014-02-08 Issue:3 Volume:165 Page:382-391
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Perry Anamarija M.¹,Alvarado-Bernal Yuridia²,Laurini Javier A.³,Smith Lynette M.⁴,Slack Graham W.⁵,Tan King L.⁵,Sehn Laurie H.⁶,Fu Kai⁷,Aoun Patricia⁸,Greiner Timothy C.⁷,Chan Wing C.⁷,Bierman Philip J.⁹,Bociek Robert G.⁹,Armitage James O.⁹,Vose Julie M.⁹,Gascoyne Randy D.⁵,Weisenburger Dennis D.⁸

Affiliation:

1. Department of Pathology; University of Manitoba; Winnipeg MB Canada

2. Division of Anatomic Pathology; University Hospital Dr. Jose E. Gonzalez; Autonomous University of Nuevo Leon; Monterrey Mexico

3. Department of Pathology; University of South Alabama; Mobile AL USA

4. Department of Biostatistics; University of Nebraska Medical Center; Omaha NE USA

5. Department of Pathology; British Columbia Cancer Agency and Center for Lymphoid Cancer; University of British Columbia; Vancouver BC Canada

6. Department of Medicine; British Columbia Cancer Agency and Center for Lymphoid Cancer; University of British Columbia; Vancouver BC Canada

7. Department of Pathology and Microbiology; University of Nebraska Medical Center; Omaha NE USA

8. Department of Pathology; City of Hope National Medical Center; Duarte CA USA

9. Department of Internal Medicine; University of Nebraska Medical Center; Omaha NE USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12763/fullpdf

Reference41 articles.

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

2. Double-hit B-cell lymphomas;Aukema;Blood,2011

3. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab;Barrans;Journal of Clinical,2010

4. Role and prognostic significance of the ki-67 index in non-hodgkin's lymphoma;Broyde;American Journal of Hematology,2009

5. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy;Choi;Clinical Cancer Research,2009

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coexpression of MYC and BCL2 oncoproteins in primary nodal versus primary extranodal diffuse large B-cell lymphoma;Journal of Laboratory Physicians;2024-09-03

2. Unmet Needs in the First-Line Treatment of Diffuse Large B-cell Lymphoma: Expert Recommendations From the Asia-Pacific Region With a Focus on the Challenging Subtypes;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Adding MYC/BCL2 double expression to NCCN-IPI may not improve prognostic value to an acceptable level;Blood Research;2024-02-19

4. The significance of concurrent MYC and BCL2 expression in Egyptian patients with diffuse large B-cell NHL;Pathology - Research and Practice;2024-01

5. Myc rearrangement and concurrent high protein expression of C-Myc/Bcl2 carry an adverse prognosis in diffuse large B-cell lymphoma;Annals of Diagnostic Pathology;2023-10